FDA Rejects Insys Painkiller Spray Over Safety Concerns
The U.S. Food and Drug Administration has rejected Insys Therapeutics Inc.'s new opioid painkilling spray over potential safety concerns, the company said....To view the full article, register now.
Already a subscriber? Click here to view full article